# Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH

> **NCT05757687** · NA · RECRUITING · sponsor: **ProArc Medical** · enrollment: 11 (estimated)

## Conditions studied

- Lower Urinary Tract Symptoms
- Benign Prostatic Hyperplasia

## Interventions

- **DEVICE:** Omega device

## Key facts

- **NCT ID:** NCT05757687
- **Lead sponsor:** ProArc Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-07
- **Primary completion:** 2026-01-03
- **Final completion:** 2026-09-01
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05757687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05757687, "Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05757687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*